SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-004392
Filing Date
2023-02-13
Accepted
2023-02-13 09:14:17
Documents
14
Period of Report
2023-02-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 64835
2 ex10-1.htm EX-10.1 221785
  Complete submission text file 0001493152-23-004392.txt   560648

Data Files

Seq Description Document Type Size
3 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT aeha-20230212.xsd EX-101.SCH 4404
4 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT aeha-20230212_def.xml EX-101.DEF 27307
5 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT aeha-20230212_lab.xml EX-101.LAB 37849
6 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT aeha-20230212_pre.xml EX-101.PRE 25927
8 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 7169
Mailing Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022
Business Address 515 MADISON AVE SUITE 8078 NEW YORK NY 10022 (646) 908-2658
Aesther Healthcare Acquisition Corp. (Filer) CIK: 0001869974 (see all company filings)

IRS No.: 871309280 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40793 | Film No.: 23615081
SIC: 2834 Pharmaceutical Preparations